Lasa Supergenerics Ltd
₹4.44
-0.23 (4.93%)
Fri, 06 Nov 2026, 07:13 pm
Health Technology
Pharmaceuticals: Major
24.5KLasa Supergenerics Share Price Live Chart
1 Day
-0.23 (4.93%)
No Result Found
Summary
Market Cap (in Cr)
23.95
Net Profit (in Cr)
-34.09
P/B
0.57
Sector P/E
50.89
P/E
0
EV/EBITDA
0
Debt/Equity (Industry)
0.19
Interest Cover (Industry)
10.20
ROCE (Industry)
7.47
RONW (Industry)
6.26
ROE
0
ROCE
0
Debt/Equity
0.09
EPS (TTM)
0
Dividend Yield
0
Book Value
9.90
Interest Cover
-31.45
Analysis
all
- Lasa Supergenerics is profitable, therefore cash runway is not a concern.
- Lasa Supergenerics is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (28.1%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 1.6x debt.
- Lasa Supergenerics's cash and other short term assets cover its long term commitments.
- Unable to evaluate Lasa Supergenerics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Lasa Supergenerics's dividend against the top 25% market benchmark as the company has not reported any payouts.
- Lasa Supergenerics's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Interest payments on debt are not well covered by earnings (EBIT is 1.9x annual interest expense, ideally 3x coverage).
- High level of physical assets or inventory.
Shareholding
| Shareholders | SEPT 2026 | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 |
|---|---|---|---|---|---|
| Promoters | 53.65 | 53.65 | 53.65 | 53.65 | 53.65 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 |
| Public | 46.35 | 46.35 | 46.35 | 46.35 | 46.35 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 6.79 | 5.88 | 5.28 | 4.97 | 4.37 | 4.06 | 3.15 |
| Fibonacci | 5.88 | 5.54 | 5.32 | 4.97 | 4.63 | 4.41 | 4.06 |
| Camarilla | 4.92 | 4.84 | 4.75 | 4.97 | 4.59 | 4.50 | 4.42 |
Pivots Level: Classic
R3
+1.82
6.79
R2
+0.91
5.88
R1
+0.30
5.28
S1
-0.61
4.37
S2
-0.91
4.06
S3
-1.82
3.15
Moving Average
Period
Value
10-EMA
5.38
20-EMA
5.95
30-EMA
6.27
50-EMA
6.63
100-EMA
7.16
200-EMA
8.36
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 09 Sept 2026 | agm | ||
| 29 May 2026 | board-meetings | Accounts, Quarterly Results | |
| 13 Feb 2026 | board-meetings | Quarterly Results | |
| 14 Nov 2025 | board-meetings | Quarterly Results | |
| 05 Sept 2025 | agm | ||
| 28 Jan 2025 | egm | ||
| 03 Sept 2024 | agm | ||
| 20 Aug 2024 | agm | Annual General Meeting | 21 Sept 2024 |
| 02 Sept 2023 | agm | ||
| 20 Aug 2023 | agm | Annual General Meeting | 21 Sept 2023 |
Peer Comparison
Lasa Supergenerics Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Divis Laboratories Ltd
Zydus Lifesciences Ltd
Laurus Labs Ltd
Lasa Supergenerics Ltd About
Lasa Supergenerics is primarily engaged in the business of manufacturing API bulk drugs products.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
2016
Headquarters
CEO
Omkar P Herlekar
Employees
Contact
Website
http://www.lasalabs.com
cs@lasalabs.com
Phone
91-2145-232101/232202
Location
C-105 MIDC, Mahad, Raigad, Maharashtra, 402301
Lasa Supergenerics Ltd Company History
| Year | History |
|---|---|
| 2013 |
|
| 2016 |
|
| 2021 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| AMIT KUMAR JAIN HUF | bulk | Buy | 398113 | 10.57 | 08 Sept 2025 |
| AMIT KUMAR JAIN HUF | bulk | Sell | 224606 | 10.65 | 08 Sept 2025 |
| BNP ENTERPRISES | bulk | Sell | 284542 | 17.28 | 22 May 2025 |
| MANBHUPINDER SINGH ATWAL | bulk | Sell | 280000 | 28.38 | 01 Jan 2024 |
| MANBHUPINDER SINGH ATWAL | bulk | Buy | 300000 | 32.8 | 27 Dec 2023 |
| PALAK INTERMEDIATES PRIVATE LIMITED | bulk | Buy | 270838 | 30.59 | 17 Feb 2023 |
| PALAK INTERMEDIATES PRIVATE LIMITED | bulk | Sell | 270838 | 29.96 | 17 Feb 2023 |
| PALAK INTERMEDIATES PRIVATE LIMITED | bulk | Buy | 773407 | 29.06 | 16 Feb 2023 |
| PALAK INTERMEDIATES PRIVATE LIMITED | bulk | Sell | 773407 | 29.13 | 16 Feb 2023 |
| SKSE SECURITIES LTD | bulk | Buy | 327891 | 41.39 | 21 Sept 2022 |
Frequently Asked Questions
1.What is the stock price of Lasa Supergenerics Ltd?
As of 07/11/2026 at 12:43 AM, Lasa Supergenerics Ltd shares are trading at ₹4.44.
2.What is the market cap. of Lasa Supergenerics Ltd?
As of 07/11/2026, the market capitalization of Lasa Supergenerics Ltd is ₹23.95 crore.
3.When was Lasa Supergenerics Ltd founded?
Lasa Supergenerics Ltd was founded in 2016.
4.How can I buy shares of Lasa Supergenerics Ltd?
You can buy shares of Lasa Supergenerics Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
5.Does Lasa Supergenerics Ltd pay dividends?
No, Lasa Supergenerics Ltd does not pay dividends to eligible shareholders currently.
6.What are the latest financial results of Lasa Supergenerics Ltd?
For the financial year ended March 2025, Lasa Supergenerics Ltd reported revenue of ₹142.00 crore and a net profit of ₹-14.76 crore.
7.What is the Stock symbol of Lasa Supergenerics Ltd?
LASA is the stock symbol of Lasa Supergenerics Ltd.
8.Who is the CEO of Lasa Supergenerics Ltd?
The CEO of Lasa Supergenerics Ltd is Omkar P Herlekar.
